Companies /Healthcare

Orasure Technologies Inc

NASDAQ: OSUR Medical Instruments & Supplies
$3.51
▼ $0.09 (−2.50%) today
Markets closed · 4:39pm ET

OSUR at a Glance

Valuation
Market cap
$248.6M
Profitability
Revenue (TTM)
$116.2M
Profit margin
-41.7%
EPS (TTM)
$-0.69
Price
52-week range
$2 – $5
Street target
$5.50

Headquartered in Bethlehem, PA Fiscal year ends December NASDAQ: OSUR orasure.com

About OraSure Technologies

OraSure Technologies, Inc. (OTI) develops, manufactures and distributes point-of-need and home diagnostic tests and sample collection and stabilization devices aimed at decentralizing diagnostics. Its operations span three areas:
- Diagnostics: rapid tests such as the OraQuick line for HIV and HCV, the newly launched OraQuick Ebola 2.0 Rapid Antigen Test, and BioMedomics' Sickle SCAN.
- Sample Management Solutions: largely through DNA Genotek, including the Colli-Pee•Dx at-home urine collection kit cleared for use with Roche's cobas STI molecular tests.
- Molecular diagnostics development: through Sherlock Biosciences.
OTI also holds an equity-method investment. Customers include clinical laboratories, hospitals, physicians' offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies and consumers. The company is pursuing a return-to-growth strategy built on new product launches, partnerships such as early HPV testing development on Colli-Pee•Dx, and cost efficiencies, while its COVID-19 testing revenue has largely run off and its risk assessment testing business has been exited. Updated

Latest Activity

OSUROraSure Technologies
Q3 2026
EPS
-$0.15
est -$0.18+16.7%
Revenue
$31M
est $31M-0.4%

Revenue grew 14% year over year, the first real sign the core business has stopped shrinking after six quarters of decline. Non-GAAP gross margin expanded to 45.9%, narrowing the loss versus expectations even though revenue slightly missed. Management guided Q4 to $30 million to $32 million.

Quarterly revenue
OSUR share price +0.00% since close

OSUR Coverage

Frequently Asked Questions

What does OraSure Technologies do?

OraSure Technologies, Inc. (OTI) develops, manufactures and distributes point-of-need and home diagnostic tests and sample collection and stabilization devices aimed at decentralizing diagnostics.

What is the OSUR stock price target?

The Wall Street consensus 12-month price target for OSUR is $5.50.